A new review highlights how the nuclear scaffold protein LaminB acts as a stress-integration gatekeeper in neurons, with ...
Kylo Peptides has added Semax [ to its research catalog this week. The compound is a synthetic peptide supplied only for laboratory and scientific research. It’s being offered in 10 mg vials. Semax ...
A research team has mapped a family of plant gene regulators across cultivated sweetpotato and three wild relatives, ...
ARO-MAPT Interim Phase 1/2a Clinical Data Demonstrating Deep and Durable Tau Reductions in Healthy Volunteers . Arrowhead’s TRiM™ platform ...
2d
If you can't use 'muscle repair,' how do you sell protein? I read the news and thought of some copy
I came across this news.It reports that Zushi City in Kanagawa Prefecture received administrative guidance for violating the ...
Researchers identify GmRVE4d as a gene that delays soybean flowering and maturity by repressing GmPRR5a. This finding highlights GmRVE4d as a potential breeding target for improving soybean adaptation ...
Practical Guidance on Storage, Reconstitution, Specifications and Custom Solutions for Global Researchers HUSTON, TX, ...
A new review synthesizes preclinical and clinical evidence showing that lipid nanoparticle biodistribution, mRNA persistence, ...
Three leading scientists in protein science, structural biology and AI will headline the Protein Sciences in Drug Discovery ...
Perspective Therapeutics announced FDA Fast Track Designation for PSV359 to treat advanced FAP-positive solitary fibrous ...
Perspective Therapeutics, Inc. (“Perspective,” the “Company,” “we,” “us,” and “our”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers ...
NSCLC development advances after FDA Breakthrough Therapy Designation for previously treated EGFR wild-type, c-Met disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results